A case report and literature review of olanzapine-associated hyperglycemia with previous history of gestational diabetes
Background: Olanzapine (Zyprexa) package labeling includes a warning for hyperglycemia, stating physicians should consider the risks and benefits when prescribing olanzapine to patients with an established diagnosis of diabetes mellitus or having borderline increased blood glucose levels. A case rep...
Main Authors: | Jennifer N. Alastanos, PharmD, BCPP, BCPS, Devika Suri, PharmD, Hayato DeLellis, PharmD, Andrea Mapugay, PharmD |
---|---|
Format: | Article |
Language: | English |
Published: |
American Association of Psychiatric Pharmacists
2022-01-01
|
Series: | Mental Health Clinician |
Subjects: | |
Online Access: | https://theijpt.org/doi/pdf/10.9740/mhc.2022.01.037 |
Similar Items
-
Opioid antagonists to prevent olanzapine-induced weight gain: A systematic review
by: S. Andrea Laguado, PharmD, BCPS, BCPP, et al.
Published: (2023-08-01) -
Quetiapine and olanzapine misuse prevalence in a US general population sample
by: Kirk E Evoy, PharmD, BCACP, BC-ADM, CTTS, et al.
Published: (2023-04-01) -
Evaluation of the use of chlorpromazine for agitation in pediatric patients
by: Rajwoana Ahmed, PharmD, et al.
Published: (2023-03-01) -
Evaluation of intramuscular olanzapine and ziprasidone in the medically ill
by: Seema M. Patel, PharmD, BCPP, et al.
Published: (2021-01-01) -
Psychotropic stewardship: Advancing patient care
by: Haight Robert J. PharmD, BCPP, et al.
Published: (2023-04-01)